In adherence to strict Non-Disclosure Agreements, Sedulo is unable to disclose identifiable information regarding our clients.
Entering a new market without the right intelligence is a costly risk. Learn how Sedulo Group equips companies with deep competitor, customer, and market insights to build confident, data-driven market entry strategies
The Situation A well-established technology provider pivoted into a new product vertical and quickly encountered a need for sharper positioning against a key incumbent. With hypotheses around competitor pricing and customer sentiment already forming internally, the company required third-party validation and deeper competitive insight to guide its marketing and sales strategy. To confidently move forward, the client partnered with Sedulo
A global technology company partnered with Sedulo Group to gain validated, actionable intelligence on competitor pricing, packaging, and value propositions across payments, identity, and compliance. Through targeted buy-side research and strategic analysis, Sedulo delivered detailed insights into competitor strategies and product differentiation. As a result, the client optimized pricing, sharpened its value propositions, and strengthened internal alignment, driving improved market performance and competitive advantage.
Sedulo crafted an early-warning monitoring program for a pharma leader focused on Parkinson’s stage therapies. Through secondary intelligence (press releases, clinical data) and primary interviews with competitor personnel, the team flagged key R&D moves, enabling the client to pivot proactively in a fast-evolving treatment space
When heightened competition threatened a coop-owned business, Sedulo delivered a multi-phase deep-dive CI initiative. Leveraging stakeholder interviews and primary research via its Persistent Source Network™, the team validated real-time intelligence and unearthed key competitive threats and opportunities. Leadership gained clarity to anticipate rival moves and enhance strategic positioning.
A U.S.-based biopharmaceutical company faced competitive pressure from upcoming cardiovascular product launches and looming generic entry. Sedulo Group delivered targeted intelligence on competitor strategies, generic threats, and market vulnerabilities through a customized monitoring program. Armed with these insights, the client implemented counter-launch tactics, adjusted pricing and distribution, and protected its market position
